139 related articles for article (PubMed ID: 11409425)
1. Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke.
Broderick J; Lu M; Jackson C; Pancioli A; Tilley BC; Fagan SC; Kothari R; Levine SR; Marler JR; Lyden PD; Haley EC; Brott T; Grotta JC;
Ann Neurol; 2001 Jun; 49(6):736-44. PubMed ID: 11409425
[TBL] [Abstract][Full Text] [Related]
2. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group.
Stroke; 1997 Nov; 28(11):2109-18. PubMed ID: 9368550
[TBL] [Abstract][Full Text] [Related]
3. Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
Ingall TJ; O'Fallon WM; Asplund K; Goldfrank LR; Hertzberg VS; Louis TA; Christianson TJ
Stroke; 2004 Oct; 35(10):2418-24. PubMed ID: 15345796
[TBL] [Abstract][Full Text] [Related]
4. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
[TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator for acute ischemic stroke.
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
N Engl J Med; 1995 Dec; 333(24):1581-7. PubMed ID: 7477192
[TBL] [Abstract][Full Text] [Related]
6. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.
Kwiatkowski TG; Libman RB; Frankel M; Tilley BC; Morgenstern LB; Lu M; Broderick JP; Lewandowski CA; Marler JR; Levine SR; Brott T
N Engl J Med; 1999 Jun; 340(23):1781-7. PubMed ID: 10362821
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. NINDS; The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
Stroke; 2000 Dec; 31(12):2912-9. PubMed ID: 11108748
[TBL] [Abstract][Full Text] [Related]
8. [ApoE genotype influences on efficacy and safety of thrombolytic treatment for ischemic stroke].
Fernández-Cadenas I; Alvarez Sabín J; Molina CA; Ribó M; Rosell A; Penalba A; Ortega L; Montaner J
Neurologia; 2006 May; 21(4):176-80. PubMed ID: 16832771
[TBL] [Abstract][Full Text] [Related]
9. Isoforms of apolipoprotein E can modulate tPA-induced clot lysis in vitro.
Clark JF; Huri DA; Carrozzella J; Jauch EC; Mehta P; Heaton D; Biehle SJ; Broderick JP
Front Biosci; 2002 Aug; 7():a163-8. PubMed ID: 12133811
[TBL] [Abstract][Full Text] [Related]
10. Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience.
Rhoney DH; Coplin WM; Lin Y; Frankel M; Lyden PD; Levine SR
J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):40-8. PubMed ID: 20123226
[TBL] [Abstract][Full Text] [Related]
11. Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
Hertzberg V; Ingall T; O'Fallon W; Asplund K; Goldfrank L; Louis T; Christianson T
Clin Trials; 2008; 5(4):308-15. PubMed ID: 18697845
[TBL] [Abstract][Full Text] [Related]
12. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
13. Effect of serum lipid levels on stroke outcome after rt-PA therapy: SAMURAI rt-PA registry.
Makihara N; Okada Y; Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Hasegawa Y; Kario K; Okuda S; Naganuma M; Toyoda K
Cerebrovasc Dis; 2012; 33(3):240-7. PubMed ID: 22261711
[TBL] [Abstract][Full Text] [Related]
14. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke.
Patel SC; Levine SR; Tilley BC; Grotta JC; Lu M; Frankel M; Haley EC; Brott TG; Broderick JP; Horowitz S; Lyden PD; Lewandowski CA; Marler JR; Welch KM;
JAMA; 2001 Dec; 286(22):2830-8. PubMed ID: 11735758
[TBL] [Abstract][Full Text] [Related]
15. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
[TBL] [Abstract][Full Text] [Related]
16. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
[TBL] [Abstract][Full Text] [Related]
17. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
[TBL] [Abstract][Full Text] [Related]
18. Dosing errors did not have a major impact on outcome in the NINDS t-PA stroke study.
Messé SR; Kasner SE; Cucchiara BL; Demchuk A; Tanne D; Ouyang B; Levine SR;
J Stroke Cerebrovasc Dis; 2011; 20(3):236-40. PubMed ID: 20656508
[TBL] [Abstract][Full Text] [Related]
19. [Intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke in a local university hospital].
Takahashi K; Iijima K; Oguro H; Bokura H; Nagai A; Yamaguchi S; Kobayashi S
No To Shinkei; 2005 Aug; 57(8):683-8. PubMed ID: 16146212
[TBL] [Abstract][Full Text] [Related]
20. Fixed Dose IV rt-PA and Clinical Outcome in Ischemic Stroke Patients With Body Weight >100 kg: Pooled Data From 3 Randomized Clinical Trials.
Majidi S; Leon Guerrero CR; Burger KM; Sigounas D; Olan WJ; Qureshi AI
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2843-2848. PubMed ID: 30076113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]